Editorial and medical disclaimer

The information published on PeptideAdvance is provided for research and educational purposes only. Nothing on this site constitutes medical advice, clinical recommendation, prescription, or endorsement of any peptide for any indication.

Several peptides discussed on this site are not FDA-approved. Some are restricted under the FDA Category 2 designation as of September 2023. The legal status of investigational peptides varies by jurisdiction and changes frequently.

Peptides should not be used for human administration outside of authorized medical care, formal clinical research, or regulatory frameworks that apply in the user's jurisdiction. Use of research-grade peptides for human administration may carry legal, safety, and pharmacological risks beyond the scope of this site to address.

Always consult a licensed healthcare professional before considering any peptide-related decision. The professional should be familiar with the specific peptide, the user's medical history, current medications, and underlying conditions. Self-prescription of peptides — including FDA-approved peptides — is not endorsed by PeptideAdvance.

Sources of peptide-related content on this site include published peer-reviewed literature, FDA regulatory documents, manufacturer prescribing information, and the editorial judgment of PeptideAdvance reviewers. We attempt to distinguish strong evidence from weak evidence and approved use from investigational use. Errors and omissions are possible — corrections may be requested at [email protected].

PeptideAdvance does not have a financial relationship with any peptide manufacturer, compounding pharmacy, or distributor. PeptideAdvance is reader-supported and operates independently.

Limitation of liability: PeptideAdvance and its operators are not responsible for actions taken on the basis of information published on this site. Users assume all responsibility for decisions related to their own health and use of any compounds discussed.